CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 92 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $192,000 | -37.7% | 45,344 | -26.6% | 0.00% | -100.0% |
| Q1 2021 | $308,000 | -60.6% | 61,772 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $781,000 | +28.7% | 61,772 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $607,000 | -34.3% | 61,772 | -33.5% | 0.00% | 0.0% |
| Q2 2020 | $924,000 | -29.5% | 92,910 | -37.3% | 0.00% | -33.3% |
| Q1 2020 | $1,310,000 | -4.1% | 148,166 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,366,000 | +56.7% | 148,166 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $872,000 | -65.6% | 148,166 | -29.8% | 0.00% | -60.0% |
| Q2 2019 | $2,532,000 | +651.3% | 210,966 | +656.2% | 0.01% | +400.0% |
| Q1 2019 | $337,000 | +31.1% | 27,900 | +61.3% | 0.00% | 0.0% |
| Q3 2018 | $257,000 | -11.7% | 17,300 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $291,000 | -51.5% | 17,300 | -34.0% | 0.00% | -50.0% |
| Q1 2018 | $600,000 | – | 26,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,253,000 | $7,097,000 | 0.26% |
| INGALLS & SNYDER LLC | 1,358,573 | $4,280,000 | 0.19% |
| RA Capital Management | 3,033,603 | $9,556,000 | 0.17% |
| Kensington Investment Counsel, LLC | 85,483 | $269,000 | 0.16% |
| Perceptive Advisors | 4,301,282 | $13,548,000 | 0.10% |
| NewEdge Wealth, LLC | 381,326 | $1,201,000 | 0.05% |
| Black Diamond Financial, LLC | 46,000 | $145,000 | 0.05% |
| Birchview Capital, LP | 20,000 | $63,000 | 0.04% |
| XTX Topco Ltd | 14,305 | $45,000 | 0.02% |
| Alyeska Investment Group, L.P. | 548,090 | $1,726,000 | 0.02% |